The Alpha 1 Lung Disease Market is estimated to be valued at US$4.99 billion in 2023 and is expected to exhibit a CAGR of 18.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview:Alpha 1 Lung Disease is a genetic disorder that causes lung and liver disease. It occurs due to the deficiency of alpha-1 antitrypsin (AAT) protein...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian